---
title: Elexacaftor/tezacaftor/ivacaftor improves chronic rhinosinusitis detected by
  magnetic resonance imaging in children with cystic fibrosis on long-term therapy
  with lumacaftor/ivacaftor
date: '2024-01-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38218661/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240114170712&v=2.18.0
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: ELX/TEZ/IVA therapy leads to improvement of CRS in eligible
  children with CF. Our data support the role of MRI for comprehensive monitoring
  of CRS disease severity and response to therapy in children with ...'
disable_comments: true
---
CONCLUSIONS: ELX/TEZ/IVA therapy leads to improvement of CRS in eligible children with CF. Our data support the role of MRI for comprehensive monitoring of CRS disease severity and response to therapy in children with ...